Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Freeflow Ventures is an early-stage venture capital firm founded in 2019 and headquartered in Berkeley, California. The firm focuses on investing in deep tech solutions that tackle challenges in human and planetary health. Since its inception, Freeflow has invested in over 30 companies, primarily utilizing proprietary intellectual property, artificial intelligence, and machine learning to expedite market entry for innovative solutions.
The firm has established a strong presence in the venture capital landscape, emphasizing its commitment to supporting science-driven founders. Freeflow Ventures operates from a single office location in Berkeley and has built a diverse portfolio that reflects its investment philosophy. The firm’s approach combines technical expertise with a deep understanding of market needs, positioning it as a key player in the early-stage investment space.
Freeflow Ventures invests in early-stage companies across various sectors, specifically targeting human health and planetary health. Their investment strategy encompasses pre-seed, seed, Series A, and Series B funding rounds, allowing them to engage with startups at different stages of development. The firm emphasizes deep tech solutions that leverage computer science, particularly in industries such as biomanufacturing, drug discovery, medical devices, diagnostics, consumer health, and therapeutics.
In the realm of planetary health, Freeflow Ventures focuses on sectors including robotics, water, energy, carbon capture, advanced manufacturing, and advanced electronics. The firm seeks to partner with science-driven founders who are committed to addressing pressing global challenges through innovative technologies. Their investment thesis is centered on supporting companies that utilize artificial intelligence and machine learning to create impactful solutions.
Freeflow Ventures has built a notable portfolio of over 30 companies, showcasing its commitment to deep tech innovations. Key portfolio companies include:
These companies exemplify Freeflow's focus on addressing critical health and environmental challenges through advanced technology. The firm’s investments reflect a strategic alignment with its mission to support science-driven founders and innovative solutions.
David Fleck: Founder & Managing Partner. David has extensive experience in venture capital and deep tech investments, having previously worked at notable firms in the industry.
Kevin Barrett: Managing Partner. Kevin brings a wealth of knowledge in early-stage investing and has a strong background in technology commercialization.
Steve Roy: Operating Partner. Steve has a track record of operational excellence and supports portfolio companies in scaling their businesses effectively.
Adam Wierman: Scientific Advisory Board Member. Adam is an expert in artificial intelligence and its applications in healthcare, providing valuable insights to the firm.
Dave Schaffer: Scientific Advisory Board Member. Dave has a strong background in biotechnology and contributes to the firm’s investment strategy in the biotech sector.
To pitch Freeflow Ventures, founders should use the contact page available at freeflow.io/contact/. It is recommended to include a comprehensive pitch deck that outlines the technology, market opportunity, and team qualifications. Founders should expect a response within a few weeks, and warm introductions are preferred but not mandatory.
In recent months, Freeflow Ventures has been active in sharing insights through blog posts that highlight their investment philosophy and portfolio companies. Topics covered include advancements in AI for drug development and reflections on Berkeley spinouts that align with their mission. These publications demonstrate the firm’s engagement with the startup community and its commitment to knowledge sharing.
Additionally, Freeflow Ventures continues to expand its portfolio, focusing on companies that leverage deep tech to address critical health and environmental challenges. Their ongoing investments reflect a strategic alignment with their mission to support science-driven founders.
What are Freeflow Ventures' investment criteria?
Freeflow Ventures focuses on early-stage companies in the sectors of human health and planetary health. They invest in pre-seed, seed, Series A, and Series B funding rounds, emphasizing deep tech solutions that leverage artificial intelligence and machine learning.
How can I pitch to Freeflow Ventures?
Founders can pitch to Freeflow Ventures through their contact page at freeflow.io/contact/. It is advisable to include a detailed overview of the technology, market potential, and team background in the pitch.
What makes Freeflow Ventures different from other investors?
Freeflow Ventures distinguishes itself by focusing specifically on deep tech innovations that address critical challenges in human and planetary health. Their expertise in artificial intelligence and machine learning enhances their ability to identify and support promising startups.
What is the geographic focus of Freeflow Ventures?
The firm primarily invests in companies based in the United States, allowing them to closely engage with their portfolio companies and provide tailored support.
What kind of post-investment involvement does Freeflow Ventures have?
Freeflow Ventures actively engages with its portfolio companies, providing mentorship, operational support, and access to their network of experts and resources to help accelerate growth.
What is the typical check size for investments?
While specific check sizes are not disclosed, Freeflow Ventures invests across various early-stage funding rounds, which typically range from pre-seed to Series B, allowing for flexibility in their investment amounts.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.